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ABSTRACT  
Huntington’s disease (HD) which usually affects the patients at middle age results from malfunctioning of the basal 
ganglia. It is characterized by cognitive impairment, involuntary movements, neuropsychiatric and psychological 
disturbances. Early motor signs of Huntington’s disease typically include the gradual onset of clumsiness, balance 
difficulties, and brief, random, fidgeting movements. A popular approach to solving symptoms arising from HD has been 
through the administration of drugs. But drugs debase human activities, thus the application of electroconvulsive 
therapy. This work proposes a genetic algorithmic (GA) simulation of chorea in HD patient as a pedestal for the design of 
a therapeutic device aimed at managing the phenomenon. Earlier efforts have led us to the formulation of such models in 
recent past. We also compared the GA model with our foremost effort: the electromechanical model, and we observe that 
the GA model adequately capture the physiological presentation of gait phenomenon in Huntington’s disease. 
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1. INTRODUCTION 
Huntington’s disease is an autosomal dominant 
neurodegenerative disorder that results from mutant 
alleles which codes a long span of trinucleotide repeats. 
Trinucleotide repeat disorders are a set of genetic 
disorders characterized by the expansion of certain 
genes of a segment of deoxyribonucleic acid (DNA) that 
contains a repeat of three nucleotides, thus exceeding the 
normal stable threshold: usually, there exists an increase 
in the number of triplet repeats as the gene is passed 
from generation to generation which results in 
abnormalities in gene expression and function [1]. Other 
such diseases caused by triplet repeat expansion are 
Fragile X syndrome, Myotonic dystrophy and Friedreich 
ataxia [1]. One of the basal ganglia disorders, HD is 
caused by dysfunction of the subcortical circuits which 
responsibility is to regulate movement and posture. The 
motivation to unveil the mystery behind HD is due to its 
inheritance pattern. As an autosomal dominant disorder, 
a 50% chance of inheritance translates to huge 
population of HD sufferers; it is a matter of time. 
Fundamentally, the study of biological cellular behavior 
depends on the understanding of how biological 
activities are governed by the connectivity of genes and 
proteins [2]. A way of representing such a connectivity is 
usually in the form of genetic regulatory networks. A 
gene network consists of a group of genes that interact 
among themselves to synthesize proteins. The types and 
amount of proteins produced by a gene network have a 
fundamental effect on the development of the gene 
network itself and on the biological systems with which 
the network interacts [2, 3]. 
Huntington’s disease (HD) is characterized by midlife 
onset and a triad of symptoms, including progressive 
involuntary movements, neuropsychiatric disturbances, 
and cognitive impairment [4]. HD is caused by an 
enlarged CAG repeat expansion in the huntingtin protein 
gene on the short arm of chromosome 4, which results in 
a diffuse neuronal degeneration preferentially involving 
striatum and cortex [4, 5]. As the disease progresses, 
motor disability develops, especially stereotypic 
involuntary movements (Huntington’s chorea). There is 
no provided treatment for delaying the development of 
the disease or to stop the progression of HD. 
Disturbances in gait are symptomatic in HD. Gait 
abnormalities in HD include reduced walking, widened 
stance width, reduced stride length and sway; gait 
variability has been shown to be  significantly higher in 
HD compared to control subjects, [6]. The work in [6] 
revealed that a common mouse model of HD is obtained 
by repeated administration of the mitochondrial toxin 3-
nitropropionic acid (3NP) which causes striatal 
neurodegeneration that results in mild dystonia and 
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bradykinesia comparable to the manifestation of HD in 
people. 
Chorea is a hallmark of Huntington disease (HD). Other 
attributes of the disease are cognitive decline and 
psychiatric impairment. It often develops early, gradually 
worsening and plateauing in late stages [7]. Motor 
dysfunction, including chorea, decrease in functional 
capacity, particularly in early HD. Chorea worsens with 
weight loss and can compromise safety with attendant 
increase in fall risk. Treating chorea is most probably the 
important part of HD management. The pathophysiology 
and neurochemical bases of HD are complex and 
incompletely understood. Dopamine and glutamate 
transmission and interactions are affected, contributing 
to striatal and cortical vulnerability featuring such 
presentations as chorea, [1, 7, 8]. Most agents 
investigated for HD chorea target the neuro transmitters 
and receptors, [9, 10, 11]. The current management of 
HD is focused on symptom reduction, because there is no 
treatment capable of halting the progressive global 
deterioration and eventual death occurring within 10–20 
years of disease onset. To this end, efforts are only 
targeted at symptomatic management of the disease: the 
goals of managing HD are to reduce the impact of the 
disease on individuals’ abilities, primarily improving 
motor function, in order to obtain a favorable impact on 
sufferers’ quality of life[4, 12]. Electroconvulsive therapy 
has been shown to resuscitate dead brain tissues in 
Parkinson’s disease[4]. For a proper application of the 
electroconvulsive therapy, a clear understanding of the 
gait mechanism must be sort. It is in line with this 
domain that this work is targeted to define the behavior 
of Huntington’s chorea in a simulation model based on 
genetic algorithm simulation technique. 
Huntington’s disease (HD) has been studied for decades 
now. A presentation that makes the study of HD an 
important one to neuroscientists of mathematics and 
physical sciences origin is the rhythmic choreitheosis 
otherwise known as the gait syndrome that accompanies 
the disease. Our earlier attempts at capturing the gait 
phenomenon have produced positive results by way of 
mathematical modelling: electromechanical, artificial 
neural network (ANN) simulation, fuzzy set and fuzzy 
logic modelling techniques. One outstanding result 
described by [13] is the biometry of gait models based on 
artificial neural network simulation and the 
electromechanical techniques the graphical 
representation of which is presented in Figure 1. Figure 1 
relates in some details the dynamic behaviour of the arm 
of HD patients in an electromechanical equation 
described in Cartesian coordinates with the ANN 
simulation of the same movement. 
The two curves ably captured the phenomenon between 
time T = 0 and time T = 28.5 representing a steady 
build-up of excitatory post synaptic potentiation (EPSP) 
that culminates in the potentiation threshold at T = 28 
milliseconds which explains the fact that they both 
approach threshold at approximately the same rate. This 
is the point in time when the inhibitory post synaptic 
potentiation (IPSP) completely failed to match the EPSP 
thereby resulting in a jerk [9]. Since the etiology of HD 
has been traced to a mutation in chromosome 4p15, and 
the pathogenesis of the disease is well known: it is 
practicable to deploy the genetic algorithm in the 
modelling of gait syndrome in HD for its probabilistic 
properties since the precipitation of action potential is 
not a sufficient but only a necessary condition for the 
production of chorea in an HD patient.  
 
Figure 1: The ANN Analysis of Arm gait of HD Patient using 
sigmoid function. 
 
A popular strategy to optimize non-linear systems with a 
large number of variables, Genetic Algorithm (GA) is a 
class of stochastic search strategies modeled after 
evolutionary mechanisms involving evolution of 
offspring from chromosomes through crossover with 
allowance for possibility of genetic mutation. GA is a 
random search optimization technique that mimics the 
natural selection process in that it randomly generates a 
new set of solutions from existing ones in order that it 
may improve on the quality of the solutions through all 
the generations [14]. In Genetic Algorithm, the crossover 
operation and the mutation operation are the two 
commonly used reproduction operators. They are user-
defined guided by experience and principle, although 
their values (rates) may also be tuned to work for a 
specific problem setting. It is however possible to use 
other operators such as regrouping, colonization-
extinction, or migration in genetic algorithms [15]. 
Crossover is a genetic operator used to vary the 
programming of a chromosome or chromosomes from 
one generation to the next. It is the major reproduction 
operator in GA that is analogous to reproduction and 
biological crossover, upon which genetic algorithms are 
based. Cross over is a process of taking more than one 
parent solutions and producing a child solution from 
them. A crossover probability (rate) that is too high may 
lead to premature convergence of the genetic algorithm: 
the crossover probabilities of between 0.60 and 0.85 are 
in common use in GAs.   
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On the other hand, mutation is a genetic operator used to 
maintain genetic diversity from one generation of a 
population of genetic algorithm chromosomes to the 
next. It is analogous to biological mutation. Mutation 
alters one or more gene values in a chromosome from its 
initial state. In mutation, the solution may change 
entirely from the previous solution. Hence GA can come 
to better solution by using mutation. Mutation occurs 
during evolution according to a user-definable mutation 
probability. This probability should be set low. If it is set 
too high, the search will turn into a primitive random 
search. A very small mutation rate may lead to genetic 
drift , i.e. change in the frequency of a gene variant in a 
population due to random sampling, (which is non-
ergodic in nature). A mutation rate that is too high may 
lead to loss of good solutions unless there is elitist 
selection. Mutation probabilities of between 0.1 and 0.25 
are in common use. The purpose of mutation in GAs is 
preserving and introducing diversity. Mutation should 
allow the algorithm to avoid local minima by preventing 
the population of chromosomes from becoming too 
similar to each other, thus slowing or even stopping 
evolution. In this work, we have made an attempt to 
advance the understanding of HD phenomenon by 
capturing the gait syndrome in a simulation model based 
on GA prowess. 
 
2. METHODOLOGY 
The procedure enunciated below elucidates the methods 
used in simulating chorea excitation using Genetic 
Algorithm. The procedure is premised on availability of 
real time data for such diseases as the Huntington’s 
disease. It is premised on using any nth order 
polynomial, 
 ( )  ∑   
 
 
   
                               (1) 
where   is the ith parameter and  
 , the ith power of the 
predicting variable x, to fit real life chorea excitation 
distribution with time using Genetic Algorithm. The GA 
procedure simulates values of the polynomial 
parameters,   , i   , 1, .  .  . ,  , and uses the Root Mean 
Square Error (RMSE), a statistical error measures 
defined as: 
     √
∑ (     )
 
   
 
                        (2) 
where: y  the data ordinate point  ,   1, 2, .  .  .  , N 
ŷ  is the predicted ordinate for data point  ,   1, 2,…,N 
to determine the best fit polynomial parameters for the 
chorea distribution.  
 
2.1 Encoding and Decoding 
Various techniques of continuous distribution 
representation using the Genetic Algorithm for 
simulation are available. However, the current approach 
to this simulation uses denary entries (0, 1, .  .  .  9) into 
strings of byte lengths L, representing each parameter 
and concatenated to form the chromosomal 
representation of a possible parameter set simulated. 
The chromosomal solution set representations are then 
decoded by simply converting the entries to decimal 
values within predetermined but viable bounds [  ,   ], 
for parameter    , 1, .  .  .,   as, 





   
                          ( ) 
In (3), a , is the upper bound of parameter value and a  is 
the lower bound of parameter value while d  
denary entry of byte position in the parameter string,    k  
1, 2, . . . , L  
 
2.2 Crossover 
One-point crossover was adopted for the evolution of 
chromosomal solutions. A crossover probability of 0.85 
was adopted. This high crossover probability was 
informed by the vast and enormous combinations of 
possible solution representations that are possible for 
denary representation as against lower u-nary 
representations. Primarily, possibilities of crossover are 
determined for pairs of possible parent-chromosomes. 
For selected parent-chromosomes, secondary 
possibilities of crossing on one parameter string or the 




Byte-wise mutation operation was done at a probability 
of 0.25. Again this high mutation probability was 
informed by the large number of exhaustive 
representation combinations that were expected for 
denary encoding. Parent chromosomes were selected 
into the mating pool based on mutation probability, 
while the string on which mutation operation was 
carried out was also determined by the same probability 
before determining which byte position to mutate on. 
 
2.4 Selection 
Selection operation was conducted using the classical 
Roulette wheel mechanism. Before selection, candidate 
chromosomes were ranked in ascending order of 
statistical measure of fitness (in this case, RMSE). The 
selection procedure allowed some elite top-ranked 
chromosomes byte into the next generation. 
 
2.5 Evaluation 
The Root Mean Square Error (RMSE) as explained above 
was used as a measure of fitness of the chromosomes 
and a basis for ranking them. The different evaluation of 
RSME was based on calculating the ordinates ŷ   (  ) 
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for each epoch   1, 2,   .  .  .  ,   in order to obtain 
deviation (error), (y   ŷ ), squaring each, summing over 
all epochs and obtaining the square root of the result. 
The parameters   ’s are the decoded values for each 
chromosome at any evaluation point. The lesser the 
RMSE, the better the chromosome solution and the more 
the chance of being selected into the ensuing generation 
of chromosomal solutions.  The step-wise procedure for 
executing the Genetic Algorithm simulation is as 
captured in the GA-Huntington-Chorea pseudo-code 
below. 
 
2.6 Programme: GA-Huntington-Chorea 
Read GA parameters, Crossover probability, p , Mutation 
probability, p , String length, L,   Population Size, s , No 
of Generations , G, No of batches, B (runs). 
Read Problem Parameters, Number of chorea data points 
N, Number of parameters n, Upper parameter bound a  
for each i ,Lower parameter bound, a , for each I, C_data 
(Chorea Data). 
b = 1  
Do While      
g = 0 
Generate Initial Population: g = 0, for g = 0, 1, 2, .  .  .  , G and  
b = 1, for b = 1, 2, 3,. .  .  , B  
Evaluate: Population    
Select:  Population   from    
Do While      
    1                                                  (4) 
Crossover: string-wise based on    
Mutate: byte-wise operation based on    
Evaluate:  Population   ; evaluate fitness based on RMSE; 
record best solutions if     
Select      from    
Loop 
 
2.7 Features of Huntington’s chorea 
A scaled-down version of the above algorithm was used 
to simulate a Huntington disease chorea data with 34 
epochs. The following are the GA and the problem 
parameters used. 
 
3. RESULTS AND DISCUSSION 
The code for executing the GA was written in Visual Basic 
11 and run on an All-in-One DEL 1.67GHz Intel Core Duo 
CPU T2300 with 512MB memory. Results were obtained 
for each generation but recorded at the end of each 
batch-run. In all, a total of 500,000 candidate-
chromosomal-solutions were generated and evaluated. 
The results for 20 batch-runs for a quadratic of the 
Huntington chorea data are as depicted in Figure 2. 
The comparative analyses of results for the 20 data 
batch-runs for the aforementioned quadratic 
interpolation of the chorea syndrome in HD of Figure 3 
above were based on the Root Mean Squared Error 
(RMSE). Figure 4 is the graphical interpretation of the 
pattern of distribution of the RMSE of Figure 3 showing 
decreasing optimal RMSE over 20 batch-runs of the GA. 
 
Table 1: Problem parameters for GA Simulation Model 
GA Parameter Assigned Value 
Crossover Probability,    0.85 
Mutation Probability,    0.25 
Population Size,    500 
No of generations, G 50 
Number of Batches, B 20 
Parameter String length, L 7 
All parameter upper bounds, a  0.1 
All parameter lower bounds, a  1   1 
   
 
 
Figure 2: Graph of GA Simulation Model for Arm Gait in HD 
Patient. 
 
Figure 3: Comparing GA Model with Electromechanical Model 
for Arm gait in HD Patient. 
 
 
Figure 4: Optimal RMSE Distribution Over 20 Batch-Runs of GA 
Simulation of Gait Syndrome in HD 
 
Figure 4 captures the distribution of the decreasing 
RMSE of the GA simulated for the Gait Syndrome in HD 
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over 20 batch-runs of the GA with 50 generations per run 
in which the chromosome with the best RMSE in every 
generation and by implication from one batch-run to the 
next was selected as an elite chromosome into the 
following generation or batch-run. The figure shows that 
a near-zero RMSE was obtained at the 20th batch-run 
eliciting the efficacy of the GA Simulation for this 
problem. 
This paper investigates the chorea phenomenon in HD: 
some jerky spasmodic movements usually of facial 
muscles, the limbs and trunks resulting from annihilation 
of key nerve cells in the caudal region especially those of 
the medium spiny strata neurons of the basal ganglia [12, 
16]. Attempts at managing Parkinsonism, a similar 
presentation associated with Parkinson’s disease (PD) 
has yielded encouraging results. One of such results is 
the Metrode Incorporated device; a nano-robot that 
manages the choreiform movements associated with PD 
with the additional quality that it rejuvenates the central 
nervous system (CNS) [4]. However, electroconvulsive 
based therapies for other prime diseases such as seizures 
and muscular contractions experienced during child 
birth have not yielded positive results. Unlike 
Parkinsonism, symptomatic treatment of Huntington’s 
chorea is chiefly done by drug administration [7, 17]. The 
ultimate goal of our study is to achieve the simulation 
model for the phenomenon which precipitates the gait 
syndrome in HD. Figure 1 is the outcome of our effort in 
this endeavour and it is in agreement with previous 
works in literature. The outcome of our research effort is 
in agreement with the existing literature [1, 5, 9, 13]. 
Figure 3 is a comparative analysis of the 
electromechanical model of gait phenomenon of [12] and 
the GA simulation model.  
According to literature, the threshold for the 
precipitation of chorea in any HD patient is largely 
dynamic depending on the potentiality of the 
physiological information in the neuronal circuit of the 
HD sufferer, [18, 19]. Important functions of the 
biochemical pathways can be responsible for chorea if 
one of two of such functions occur simultaneously. These 
functions usually culminate in the boosting of weak 
signals and the ability to suppress over-activity. The 
processes that culminate in action potential and 
consequently a jerk where the IPSP is in short supply 
relative to the EPSP include: convergence phenomena 
where signals from different parts of the CNS may serve 
as input into a single motor neuron; divergence 
phenomena when a single neuron sends out collateral 
which serve as input to few or very many other neurons; 
temporal facilitation whereby increase in excitability 
brought about by successive excitatory post-synaptic 
potential (EPSP), earlier EPSP may facilitate effects of 
later EPSP in triggering nerve impulse and the effect of 
several such stimuli occurring in rapid succession is 
greater than the sum of the effect of individual stimulus 
while spatial facilitation occur when the effect of several 
simultaneous stimuli is greater than the sum of the effect 
of individual stimulus; synaptic facilitation involving 
repeated use of synapse results in considerable increase 
in synaptic potentials and a way of facilitating repetition 
of neuronal activities; occlusion is said to exist where the 
effect of many stimuli produced in rapid succession or 
simultaneously is less than the sum effect of individual 
stimuli [8, 20]. One or more of the aforementioned 
processes may have been responsible for distinct 
threshold levels in Figure 2 and Figure 3 [4, 21, 22, 23]. 
The paper investigates the chorea; a physiological 
attribute of HD, and presents in some detail the dynamic 
behaviour of HD in the arm of patients using genetic 
algorithm. It is often said that the etiology of HD is not 
yet fully understood but increasing evidence suggests 
that the steady progression of motor dysfunction which 
takes place in Huntington’s disease cannot be isolated 
from the role of altered gene transcription, 
mitochondrial dysfunction and excito-toxicity 
consequent upon which is the distortion of smooth 
motion especially of the arms and this is considered as a 
major indicator of pre-symptomatic HD progression [24]. 
The analysis of these movements of the arm, which has 
been found to be in agreement with existing literatures 
in that regard, led to the generation of the model. The 
work is a consolidation on our previous exploration in 
the modeling of the chorea syndrome that characterizes 
the Huntington’s disease. Figure   is only a confirmation 
of the convergence of the GA phenomenon [25].The 
results provide a springboard for further promotion of 
the understanding of HD with a view to proffer a 
management mechanism to a physiological presentation 
of the disease. The paper considered the global case 
without recourse to the stage of the disease.  
 
4. CONCLUSION 
In this paper, we have harmonized various works on 
choreic disorders to propose a uniquely formulated 
simulation model of the chorea phenomenon in 
Huntington’s disease based on genetic algorithm. Our 
earlier research efforts on gait syndrome in HD have 
produced various models for the physiological 
presentation of choreiform movements in HD. The 
genetic algorithm being an evolutionary programming 
approach searches from one population of points to 
another with focus on the best solution while sampling 
the total parameter space on continuous basis[23]. One 
feature of GA algorithm that made it captivating for this 
process is the number of sub-processes such as 
crossover, mutation to mention but a few, that brought 
the procedure intimately connected to the etiological 
agent of HD. It is our believe that with this work we have 
been able to promote a better understanding of the 
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disorder once describe by George Huntington as an 
heirloom in the dim past generation. 
In the nearest future we hope to capture the 
physiological presentation with neuro-fuzzy simulation 
and Markov chain procedures. It is believed that this 
work will provide the necessary pedestal for future work 
in this area of academic endeavour. 
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